# CoreRX Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa

> Inspection records and compliance data for CoreRX Inc. in Clearwater, Florida. Access full analysis and detailed observations.

---

## Details

- Name: CoreRX Inc.
- FEI Number: 3007209985
- City: Clearwater
- State: Florida
- Country Name: United States
- Address Line 1: 14205 Myerlake Cir
- Zip Code: 33760
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK, REPACK

## Related Documents

- [FDA Inspection 1304588 - CoreRX Inc. - 2026-02-26](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/956f34ef-816f-43f4-bdfd-ba4552b1e37e) — source: FDA, date: February 26, 2026
- [483 - CoreRX Inc. - 2025-03-20](https://www.globalkeysolutions.net/records/483/corerx-inc/4e925761-65a5-468e-a5d9-c170685d7857) — source: FDA, date: March 20, 2025
- [FDA Inspection 1264769 - CoreRX Inc. - 2025-03-20](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/2ad11a9c-e4df-4503-8667-a3b01206638f) — source: FDA, date: March 20, 2025
- [FDA Inspection 1151289 - CoreRX Inc. - 2021-08-13](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/85fa8ce0-d79f-4073-a991-3e6bc3437b59) — classification: No Action Indicated (NAI), source: FDA, date: August 13, 2021
- [483 - CoreRX Inc. - 2020-03-06](https://www.globalkeysolutions.net/records/483/corerx-inc/c5d7672d-dfb4-4e43-ac1d-b08c5c9efdb1) — source: FDA, date: March 6, 2020
- [FDA Inspection 1119912 - CoreRX Inc. - 2020-03-06](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/bc103bf0-449a-4325-ade3-a111f8251fb5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 6, 2020
- [483 - CoreRX Inc. - 2019-06-21](https://www.globalkeysolutions.net/records/483/corerx-inc/4c534536-5911-42dd-8cf5-a28e860ef746) — source: FDA, date: June 21, 2019
- [483 - CoreRX Inc. - 2019-06-14](https://www.globalkeysolutions.net/records/483/corerx-inc/7f68df2f-6919-4a4a-9d5d-425416d88e52) — source: FDA, date: June 14, 2019
- [FDA Inspection 1027540 - CoreRX Inc. - 2017-09-27](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/5dc2a719-2d30-4fea-aac4-3d3b22c4b12e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2017
- [FDA Inspection 932712 - CoreRX Inc. - 2015-06-19](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/73d46fa9-2206-4650-9918-4d734a61927a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2015
- [FDA Inspection 932712 - CoreRX Inc. - 2015-06-19](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/e6befd13-5536-46d5-a551-1251f167a126) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2015
- [FDA Inspection 932712 - CoreRX Inc. - 2015-06-19](https://www.globalkeysolutions.net/records/fda_inspections/corerx-inc/0223820a-068a-4561-a464-531862e6f326) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2015
- [483 - CoreRX Inc. - 2014-01-24](https://www.globalkeysolutions.net/records/483/corerx-inc/ab98b6ba-9be2-497c-bee5-bc2f3c60eef0) — source: FDA, date: January 24, 2014

## Related Companies

- [Mylan Laboratories Limited](https://www.globalkeysolutions.net/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Jubilant HollisterStier LLC](https://www.globalkeysolutions.net/companies/jubilant-hollisterstier-llc/2f8cb6dd-3555-4528-a2d6-d3b845d229ba)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.globalkeysolutions.net/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Novitium Pharma LLC](https://www.globalkeysolutions.net/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a)
- [Cipla Limited](https://www.globalkeysolutions.net/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)
- [Seqirus Inc](https://www.globalkeysolutions.net/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [Nephron Sc Inc](https://www.globalkeysolutions.net/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [Charles River Laboratories Inc](https://www.globalkeysolutions.net/companies/charles-river-laboratories-inc/876b68d9-6285-4039-8732-05f876b5d911)
- [Glenmark Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)
- [Oxford Pharmaceuticals, LLC](https://www.globalkeysolutions.net/companies/oxford-pharmaceuticals-llc/5294310a-05a2-4599-bf9e-720929f040ee)

## Related Officers

- [Approval Manager](https://www.globalkeysolutions.net/people/michael-h-tollon/5e30e7e1-5727-4169-8faf-e5d5783ac781)
- [investigator](https://www.globalkeysolutions.net/people/mizanne-e-lewis/c79964ac-5163-44a2-89e9-8cc8775de9b4)
- [Jennifer Bridgewater, Assoc. Dir. for Reg. Policy](https://www.globalkeysolutions.net/people/jennifer-bridgewater-assoc-dir-for-reg-policy/573a7b9f-6b6d-427c-9893-2b5a3b758ed0)
- [Laura Fortun, CSO](https://www.globalkeysolutions.net/people/laura-fortun-cso/66af427d-5dc3-4270-97b5-376dd1b55cf7)
- [Jose F. Velez](https://www.globalkeysolutions.net/people/jose-f-velez/0d1951e8-3aa5-48ff-bc54-1fae8a7a57c9)
- [Naveen B Kanthamneni](https://www.globalkeysolutions.net/people/naveen-b-kanthamneni/b6ac825f-1ec8-4857-b772-86ae2c6ea1cd)